A Genetic Risk Factor for Periodic Limb Movements in Sleep
NEJM 357:639-647, Stefansson,H.,et al, 2007
A Controlled Study of Additional sr-L-dopa in L-dopa-responsive Restless Legs Syndrome with Late-Night Symptoms
Neurol 52:285-290, Collado-Seidel,V.,et al, 1999
Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease
JAMA Neurol 73:668-674, Martikainen, M.H.,et al, 2016
Sequential Compression Devices for Treatment of Restless Legs Syndrome
Medicine 86:317-323, Eliasson,A.H. &Lettieri,C.J., 2007
Efficacy of Cabergoline in Restless Legs Syndrome, A Placebo-Controlled Study with Polysomnography (CATOR)
Neurol 67:1040-1046, Oertel,W.H.,et al, 2006
Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003
Long-Term Follow-Up on Restless Legs Syndrome Patients Treated with Opioids
Mov Disord 16:1105-1109, Walters,A.S.,et al, 2001
Safety of Pramipexole in Patients with Restless Legs Syndrome
Neurol 55:1589-1590, Stiasny,K.,et al, 2000
Restless Legs Syndrome Improved By Pramipecole, A Double-Blind Randomized Trial
Neurol 52:938-943, Montplaisir,J.,et al, 1999
Encouraging Initial Response of Restless Legs Syndrome to Pramipexole
Neurol 51:1221-123, Becker,P.M.,et al, 1998
Neurologic Disorders in Renal Failure (1st of Two Parts)
NEJM 294:143, Raskin,N.H.,et al, 1976
Neurologic Syndrome Associated with Antipsychotic Drug Use
NEJM 289:20, 1973, 290:110974., , 1974